Sumitoma Pharma US
Brittny Pulley is a seasoned professional in the pharmaceutical industry, currently serving as Director of CMC Manufacturing at Sumitomo Pharma America, Inc. since April 2021, following a merger where Enzyvant became known as SMPA. Before this role, Brittny held various positions including Associate Director and Senior Manager cGMP Manufacturing at Enzyvant, where responsibilities included leading cGMP manufacturing support and driving production throughput. Previous experience includes operations management at Merck, where continuous improvement projects were implemented, and expertise in aseptic processing at Novo Nordisk. Brittny's career also includes quality assurance roles at Merck & Co. and operational management at Sonic Drive. Currently pursuing a Doctor's Degree in Strategic Leadership at Liberty University, Brittny holds a Master of Science in Pharmaceutical Sciences and a Bachelor of Arts in Chemistry.
This person is not in any teams
This person is not in any offices
Sumitoma Pharma US
2 followers
Sumitomo Pharma America (SMPA) is a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need in oncology, urology, women’s health, rare disease, cell and gene therapies and psychiatry and neurology.